000484540 000__ 01672cam\a2200337Ia\4500
000484540 001__ 484540
000484540 005__ 20210513170800.0
000484540 006__ m\\\\\o\\d\\\\\\\\
000484540 007__ cr\cn|||||||||
000484540 008__ 120711s2012\\\\dcu\\\\\ob\\\\001\0\eng\d
000484540 020__ $$z9780309225496
000484540 020__ $$z0309225493
000484540 035__ $$a(CaPaEBR)ebr10606357
000484540 035__ $$a(OCoLC)813285771
000484540 040__ $$aCaPaEBR$$cCaPaEBR
000484540 05014 $$aRJ560$$b.C666 2012eb
000484540 1102_ $$aCommittee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)
000484540 24510 $$aSafe and effective medicines for children$$h[electronic resource] :$$bpediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /$$cCommittee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.
000484540 260__ $$aWashington :$$bNational Academies Press,$$c2012.
000484540 300__ $$axxiii, 408 p.
000484540 504__ $$aIncludes bibliographical references and index.
000484540 506__ $$aAccess limited to authorized users.
000484540 650_0 $$aPediatric pharmacology.
000484540 650_0 $$aDrugs$$xSafety measures.
000484540 7001_ $$aField, Marilyn J.$$q(Marilyn Jane)
000484540 7001_ $$aBoat, Thomas F.
000484540 7102_ $$aInstitute of Medicine (U.S.).$$bBoard on Health Sciences Policy.
000484540 7102_ $$aNational Academies Press (U.S.)
000484540 852__ $$bebk
000484540 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10606357$$zOnline Access
000484540 909CO $$ooai:library.usi.edu:484540$$pGLOBAL_SET
000484540 980__ $$aEBOOK
000484540 980__ $$aBIB
000484540 982__ $$aEbook
000484540 983__ $$aOnline